TY - JOUR
T1 - Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites
T2 - Structure-activity relationship and molecular-modeling studies
AU - Chen, Dapeng
AU - Wang, Ching Y.
AU - Lambert, Joshua D.
AU - Ai, Ni
AU - Welsh, William J.
AU - Yang, Chung S.
N1 - Funding Information:
We thank Mr. Marlon Lee for technical assistance, and Mrs. Dorothy Wong and Drs. Jungil Hong and Xiaofeng Meng for help in the preparation of this manuscript. This study was supported by National Institutes of Health (NIH) Grant CA88691.
PY - 2005/5/15
Y1 - 2005/5/15
N2 - (-)-Epigallocatechin-3-gallate (EGCG) is the major polyphenol present in green tea. We previously demonstrated that EGCG was both a substrate and potent inhibitor of human liver cytosolic catechol-O-methyltransferease (COMT). We now report the structure-activity relationship for the inhibition of COMT-catalyzed O-methylation of catecholestrogens in human liver cytosol by tea catechins and some of their metabolites. The most potent inhibitors were catechins with a galloyl-type D-ring, including EGCG (IC50 = 0.07 μM), 4″-O-methyl-EGCG (IC50 = 0.10 μM), 4′,4″-di-O- methyl-EGCG (4′,4″-DiMeEGCG) (IC50 = 0.15 μM), and (-)-epicatechin-3-gallate (ECG) (IC50 = 0.20 μM). Catechins without the D-ring showed two to three orders of magnitude less inhibitory potency. Enzyme kinetic analyses revealed that EGCG behaved as a mixed inhibitor, whereas 4′,4″-di-O-methyl-EGCG exhibited competitive kinetics for the S-adenosylmethionine (SAM), and noncompetitive kinetics for the catechol binding site. These compounds may represent a new type of COMT inhibitor. In silico molecular-modeling studies using a homology model of human COMT were conducted to aid in the understanding the catalytic and inhibitory mechanisms. Either D-ring or B-ring of EGCG could be accommodated to the substrate binding pocket of human COMT. However, the close proximity (2.6 Å) of 4″-OH to the critical residue Lys144, the higher acidity of the hydroxyl groups of the D-ring, and the hydrophobic interactions between the D-ring and residues in the binding pocket greatly facilitated the interaction of the D-ring with the enzyme, and resulted in increased inhibitory potency. These results provide mechanistic insight into the inhibition of COMT by commonly consumed tea catechins.
AB - (-)-Epigallocatechin-3-gallate (EGCG) is the major polyphenol present in green tea. We previously demonstrated that EGCG was both a substrate and potent inhibitor of human liver cytosolic catechol-O-methyltransferease (COMT). We now report the structure-activity relationship for the inhibition of COMT-catalyzed O-methylation of catecholestrogens in human liver cytosol by tea catechins and some of their metabolites. The most potent inhibitors were catechins with a galloyl-type D-ring, including EGCG (IC50 = 0.07 μM), 4″-O-methyl-EGCG (IC50 = 0.10 μM), 4′,4″-di-O- methyl-EGCG (4′,4″-DiMeEGCG) (IC50 = 0.15 μM), and (-)-epicatechin-3-gallate (ECG) (IC50 = 0.20 μM). Catechins without the D-ring showed two to three orders of magnitude less inhibitory potency. Enzyme kinetic analyses revealed that EGCG behaved as a mixed inhibitor, whereas 4′,4″-di-O-methyl-EGCG exhibited competitive kinetics for the S-adenosylmethionine (SAM), and noncompetitive kinetics for the catechol binding site. These compounds may represent a new type of COMT inhibitor. In silico molecular-modeling studies using a homology model of human COMT were conducted to aid in the understanding the catalytic and inhibitory mechanisms. Either D-ring or B-ring of EGCG could be accommodated to the substrate binding pocket of human COMT. However, the close proximity (2.6 Å) of 4″-OH to the critical residue Lys144, the higher acidity of the hydroxyl groups of the D-ring, and the hydrophobic interactions between the D-ring and residues in the binding pocket greatly facilitated the interaction of the D-ring with the enzyme, and resulted in increased inhibitory potency. These results provide mechanistic insight into the inhibition of COMT by commonly consumed tea catechins.
UR - http://www.scopus.com/inward/record.url?scp=18044364832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18044364832&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2005.01.024
DO - 10.1016/j.bcp.2005.01.024
M3 - Article
C2 - 15857617
AN - SCOPUS:18044364832
SN - 0006-2952
VL - 69
SP - 1523
EP - 1531
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 10
ER -